Cite
HARVARD Citation
Waldron-Lynch, F. et al. (2014). Rationale and study design of the Adaptive study of IL-2 dose on regulatory T cells in type 1 diabetes (DILT1D): a non-randomised, open label, adaptive dose finding trial. BMJ open. 4 (6), p. . [Online].